NATH BIOGENES (INDIA)
Back to All Ratios
|
NATH BIOGENES (INDIA) Last 5 Year Cash Earnings per Share (CEPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| CEPS(Rs) | 22.32 | 22.56 | 20.01 | -33.84 | 10.16 |
What is the latest Cash Earnings per Share (CEPS) ratio of NATH BIOGENES (INDIA) ?
| Year | Cash Earnings per Share (CEPS) |
|---|---|
| Mar2025 | 22.32 |
| Mar2024 | 22.56 |
| Mar2023 | 20.01 |
| Mar2022 | -33.84 |
| Mar2013 | 10.16 |
How is Cash Earnings per Share (CEPS) of NATH BIOGENES (INDIA) Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2025 | 22.32 | -1.06 | |
| Mar2024 | 22.56 | 12.74 | |
| Mar2023 | 20.01 | Positive | |
| Mar2022 | -33.84 | Negative | |
| Mar2013 | 10.16 | - | |
Other Financial Ratios of NATH BIOGENES (INDIA)
| Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹321.1 Cr | -2.3% | -2.1% | -11.7% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹13,294.7 Cr | -2.5% | 3.3% | -28.6% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹5,011.2 Cr | -5.5% | -8.1% | 7.7% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,881.8 Cr | -13.2% | -10.3% | -25.6% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,264.8 Cr | -1.6% | -3.3% | -24.5% | Stock Analytics | |
| INDO US BIOTECH | ₹263.5 Cr | -3.5% | -0.4% | -51.9% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | -2.3% |
-2.1% |
-11.7% |
| SENSEX | -0.1% |
2.6% |
6.5% |
You may also like the below Video Courses